Correction of canine X-linked severe combined immunodeficiency by in vivo retroviral gene therapy

X-linked severe combined immunodeficiency (XSCID) is characterized by profound immunodeficiency and early mortality, the only potential cure being hematopoietic stem cell (HSC) transplantation or gene therapy. Current clinical gene therapy protocols targeting HSCs are based upon ex vivo gene transfe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ravin, Suk See Ting–De, Kennedy, Douglas R., Naumann, Nora, Kennedy, Jeffrey S., Choi, Uimook, Hartnett, Brian J., Linton, Gilda F., Whiting-Theobald, Narda L., Moore, Peter F., Vernau, William, Malech, Harry L., Felsburg, Peter J.
Format: Artigo
Idioma:Inglês
Publicat: The American Society of Hematology 2006
Matèries:
Gene Therapy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895747/
https://ncbi.nlm.nih.gov/pubmed/16384923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-10-4057
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars